TRANS Government Research Act
- Sponsor
- Rep. Mace, Nancy [R-SC-1]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Aug 20, 2026
Bottom line
The bill seeks to eliminate all federal funding for research into the effects of gender-affirming medical treatments and related bodily alterations, based on a strict biological definition of sex.
What it actually does
This bill, titled the "TRANS Government Research Act," prohibits the use of any Federal funds to directly or indirectly conduct, support, or fund research that studies the effects of gender-related medical treatment or any other means of altering a person's body or physical appearance to no longer correspond to their biological sex. It includes extensive definitions for "gender-related medical treatment," specifying various surgical procedures, hormone therapies, and puberty blockers for both biological males and females, and defines "sex" based on reproductive systems.
Proponents argue
Proponents argue that this bill ensures federal taxpayer dollars are not used to support research into medical treatments that they believe are harmful, experimental, or against traditional understandings of sex and gender. They contend that such research may promote interventions that disrupt natural development or functions, and that the government should not legitimize or fund studies on these practices.
Opponents contend
Opponents contend that this bill represents a significant governmental overreach into medical science and patient care, effectively halting critical research into gender-affirming treatments. They argue that prohibiting such research will prevent the development of evidence-based care, potentially harming transgender individuals by limiting understanding of treatment efficacy and safety, and that it is discriminatory against transgender people and the medical community.
The bill is short and clearly written, making it accessible for a quick read and understanding of its core provisions.
Section 1
Short Title
This section establishes the official short title of the Act as the "Terminating Radical Attempts to Negate Sex Through Government Research Act" or the "TRANS Government Research Act." This title clearly communicates the bill's intent and subject matter.
Supporters argue
Supporters argue that the short title clearly and accurately reflects the bill's purpose, making it easy for the public and policymakers to understand its focus on research related to gender and sex.
Critics contend
Critics may argue that the short title uses inflammatory language ("Radical Attempts to Negate Sex") and an acronym ("TRANS") in a derogatory manner, which could be seen as disrespectful and politicizing a medical and personal issue.
Tradeoffs
The title aims for clarity and impact, but its phrasing may alienate or offend certain groups, highlighting the contentious nature of the bill's subject matter.
Section 2(a)
Prohibition on Federal Funds for Covered Research
This provision broadly prohibits the use of any Federal funds, regardless of other laws, to directly or indirectly conduct, support, or fund research that falls under the definition of "covered research." This means no federal money can be used for studies related to gender-affirming medical treatments or any methods of altering physical appearance to not align with one's biological sex.
Section 2(b)(1)
Definition of "Covered Research"
This section defines "covered research" as any research studying the effects of "gender-related medical treatment" or any other means of altering a person's body or physical appearance to no longer correspond to their biological sex. This includes disrupting natural development, inhibiting natural functions, or modifying physical appearance or attire. This broad definition ensures that the prohibition extends beyond just medical treatments to a wider range of interventions.
Section 2(b)(3)
Definition of "Gender-Related Medical Treatment"
This provision provides a highly detailed definition of "gender-related medical treatment," separating it into treatments for individuals perceived as not female and those perceived as not male. It lists numerous specific surgical procedures (e.g., vaginectomy, phalloplasty, penectomy, vaginoplasty), hormone therapies (e.g., exogenous testosterone, estrogen), and puberty blockers (GnRH agonists, synthetic drugs) for each category. This specificity aims to leave no ambiguity about what medical interventions are covered by the research funding prohibition.
Section 2(b)(2), (4), (5)
Definitions of "Female," "Male," and "Sex"
This section defines "female" as an individual who, but for anomaly or accident, naturally has a reproductive system producing eggs for fertilization, and "male" similarly for sperm. "Sex" is defined as the biological determination of whether an individual is male or female. These definitions establish a strict biological and reproductive-centric understanding of sex, which forms the foundation for the bill's scope regarding gender-related medical treatment.
The definition of "covered research" extends beyond "gender-related medical treatment" to include research on "any other means of altering the body or physical appearance of a person to no longer correspond to the sex of such person, including by—(i) disrupting the natural development of the body of such person; (ii) inhibiting the natural functions of the body of such person; and (iii) modifying the physical appearance or attire of such person."
Section 2(b)(1)(B)
Why it matters:While definitions are standard, the expansive nature of this clause, particularly the inclusion of "modifying the physical appearance or attire," could be easily overlooked by a reader focused on the medical aspects. It could be seen as an attempt to broaden the bill's scope significantly without drawing immediate attention to its full implications.
Case for: Supporters would argue this clause is necessary to ensure the bill's intent to prohibit research on all forms of gender alteration is comprehensive, preventing circumvention through non-medical or less invasive means. It aims to cover the full spectrum of interventions that seek to change one's presentation from their biological sex.
Case against: Critics would argue that this clause is excessively broad and potentially infringes on research into areas far removed from medical interventions, such as sociological studies of gender expression or even fashion. The inclusion of "attire" is particularly concerning, as it could be interpreted to stifle research on social aspects of gender presentation, which are distinct from medical treatments.
Estimated impact: This provision significantly broadens the scope of prohibited research beyond clinical medical treatments, potentially impacting a wider array of social science and psychological studies related to gender expression and identity.